Lakefront Biotherapeutics | GLPG - Cost Of Sales

Stock Price
23.02
Daily Change
0.12 0.52%
Monthly
-7.40%
Yearly
-9.65%
Q2 Forecast
22.89

Lakefront Biotherapeutics reported EUR4.8M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
argenx SE USD 121M 28.69M Mar/2026
AstraZeneca USD -204M 3.48B Mar/2026
Biogen USD 797.5M 302M Mar/2026
Genmab DKK 81M 23M Dec/2025
Gilead Sciences USD 1.44B 174M Mar/2026
GlaxoSmithKline GBP 1.88B 736M Mar/2026
GRIFOLS EUR 1.08B 214.82M Mar/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Incyte USD 104.5M 16.68M Mar/2026
Merck EUR 2.07B 219M Mar/2026
Neurocrine Biosciences USD 13.8M 3.8M Mar/2026
Novartis USD 3.46B 83M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 3.67B 621M Mar/2026
UCB EUR 1.07B 146M Dec/2025
Vertex Pharmaceuticals USD 392.8M 73.2M Mar/2026